N-(2-hydroxyethyl)-3-(6-(thiophen-2-yl)imidazo[1,2-b]pyridazin-3-yl)benzamide

ID: ALA4211112

PubChem CID: 145964782

Max Phase: Preclinical

Molecular Formula: C19H16N4O2S

Molecular Weight: 364.43

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(NCCO)c1cccc(-c2cnc3ccc(-c4cccs4)nn23)c1

Standard InChI:  InChI=1S/C19H16N4O2S/c24-9-8-20-19(25)14-4-1-3-13(11-14)16-12-21-18-7-6-15(22-23(16)18)17-5-2-10-26-17/h1-7,10-12,24H,8-9H2,(H,20,25)

Standard InChI Key:  JWBPROUPZLNYFD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   19.0090   -1.8751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0090   -2.7001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7211   -3.1084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7211   -1.4584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4332   -1.8751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4376   -2.6965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2202   -2.9470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6996   -2.2789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2130   -1.6170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2976   -3.1159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5434   -2.7815    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.9922   -3.3954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4058   -4.1094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2125   -3.9365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2189   -3.7711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5024   -4.1823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5013   -5.0067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2160   -5.4206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9332   -5.0044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9308   -4.1814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7862   -5.4182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0723   -5.0047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7850   -6.2432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3573   -5.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6434   -5.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9283   -5.4142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  2  0
  2 10  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  7 15  1  0
 17 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4211112

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 364.43

Molecular Weight (Monoisotopic): 364.0994

AlogP: 2.85

#Rotatable Bonds: 5

Polar Surface Area: 79.52

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.95

CX LogP: 2.41

CX LogD: 2.41

Aromatic Rings: 4

Heavy Atoms: 26

QED Weighted: 0.57

Np Likeness Score: -2.06

References

1. Koltun DO, Parkhill EQ, Kalla R, Perry TD, Elzein E, Li X, Simonovich SP, Ziebenhaus C, Hansen TR, Marchand B, Hung WK, Lagpacan L, Hung M, Aoyama RG, Murray BP, Perry JK, Somoza JR, Villaseñor AG, Pagratis N, Zablocki JA..  (2018)  Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).,  28  (3): [PMID:29254643] [10.1016/j.bmcl.2017.10.040]

Source

Source(1):

• Scientific Literature